Citigroup Cuts Amrize (NYSE:AMRZ) Price Target to $58.00

Amrize (NYSE:AMRZFree Report) had its target price lowered by Citigroup from $66.00 to $58.00 in a research note published on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock.

Other analysts have also recently issued reports about the company. Morgan Stanley set a $63.00 price objective on Amrize and gave the stock an “overweight” rating in a report on Monday, June 22nd. Stephens reaffirmed an “overweight” rating and issued a $65.00 target price on shares of Amrize in a research note on Monday, May 18th. Sanford C. Bernstein reissued an “outperform” rating on shares of Amrize in a research note on Monday, June 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a report on Friday, June 26th. Finally, Weiss Ratings cut shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Amrize has a consensus rating of “Moderate Buy” and a consensus price target of $60.57.

View Our Latest Report on Amrize

Amrize Stock Up 0.8%

NYSE AMRZ opened at $46.75 on Tuesday. The stock has a market capitalization of $25.85 billion, a P/E ratio of 21.54, a price-to-earnings-growth ratio of 0.99 and a beta of 0.11. Amrize has a 52 week low of $46.03 and a 52 week high of $65.94. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The stock has a fifty day moving average of $51.35 and a 200-day moving average of $54.52.

Amrize (NYSE:AMRZGet Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). The firm had revenue of $3.50 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.17%. On average, equities research analysts forecast that Amrize will post 2.72 EPS for the current year.

Amrize Announces Dividend

The business also recently announced a dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th will be issued a dividend of $0.11 per share. The ex-dividend date is Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is 20.28%.

Insider Activity

In related news, insider Stephen S. Clark bought 5,260 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was bought at an average cost of $47.31 per share, for a total transaction of $248,850.60. Following the transaction, the insider owned 10,637 shares of the company’s stock, valued at $503,236.47. This represents a 97.82% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nollaig Forrest purchased 2,000 shares of the stock in a transaction dated Friday, May 22nd. The stock was bought at an average cost of $50.25 per share, with a total value of $100,500.00. Following the completion of the purchase, the insider owned 20,139 shares in the company, valued at $1,011,984.75. The trade was a 11.03% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have purchased 41,329 shares of company stock valued at $2,007,181. Insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Several large investors have recently bought and sold shares of the company. Bessemer Group Inc. boosted its holdings in shares of Amrize by 20,993.0% during the 4th quarter. Bessemer Group Inc. now owns 703,453 shares of the company’s stock worth $38,646,000 after buying an additional 700,118 shares during the period. Gulf International Bank UK Ltd acquired a new position in Amrize in the 4th quarter valued at about $1,219,000. HighTower Advisors LLC bought a new position in Amrize in the 4th quarter valued at about $1,516,000. KBC Group NV bought a new position in Amrize in the 4th quarter valued at about $597,000. Finally, MASTERINVEST Kapitalanlage GmbH lifted its position in Amrize by 252.8% during the fourth quarter. MASTERINVEST Kapitalanlage GmbH now owns 36,689 shares of the company’s stock worth $2,016,000 after acquiring an additional 26,289 shares during the last quarter.

Key Stories Impacting Amrize

Here are the key news stories impacting Amrize this week:

  • Positive Sentiment: Five Amrize insiders, including CFO Baris Oran and CTO Roald Brouwer, collectively purchased 14,828 shares worth approximately $697,479 on August 11. The purchases increased their individual holdings by roughly 5% to 98%, which may signal that management views the recent decline as an attractive entry point. CFO insider purchase filing
  • Neutral Sentiment: The insider purchases occurred near $46.36 to $47.38 per share, close to Amrize’s recent trading range and its 52-week low of $46.03. While insider buying can support investor sentiment, the transactions are relatively small compared with the company’s approximately $25.9 billion market capitalization. Amrize stock information
  • Negative Sentiment: RBC Capital downgraded Amrize to “Sell,” adding an explicit bearish analyst view. The downgrade may pressure the stock by raising concerns about earnings, valuation, or the outlook, although no specific rationale was provided in the available report. RBC Capital downgrades Amrize to Sell

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.